A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease (NCT06717698)
Efficacy, Safety and Pharmacokinetics of NNC0519-0130 Once Weekly s.c. Versussemaglutide 1.0 mg and Placebo in People With Chronic Kidney Disease, With or Without Type 2 Diabetes, and With Overweight or Obesity: a Proof-of-concept and Dose-finding Study
🩺 Plain-English Summary (8th-Grade Level)
The study evaluates the safety of different doses of a new medicine called NNC0519 0130. It also looks into how the medicine may improve kidney function in participants with chronic kidney disease with or without type 2 diabetes, living with overweight or obesity. The participants will either get NNC0519-0130 (a new medicine), semaglutide (a medicine that doctors can already prescribe), or placebo (a "dummy" substance). Which treatment the participant will get is decided by chance. The study will last for up to 43 weeks.
Who can join: Review the eligibility criteria below.
Location: N America Res Inst - San Dimas — San Dimas, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (147 Sites)
Showing the first 25 of 147 sites.
- N America Res Inst - San Dimas — San Dimas, California
- NorCal Endocrinology and Internal Medicine — San Ramon, California
- Rocky Mount Reg VA Med-DN — Aurora, Colorado
- Northeast Research Institute — Fleming Island, Florida
- Encore Medical Research LLC — Hollywood, Florida
- Northeast Research Institute — Saint Augustine, Florida
- Clinical Research of Cent FL — Winter Haven, Florida
- Endeavor Health — Skokie, Illinois
- Velocity Clin. Res Valparaiso — Valparaiso, Indiana
- Elite Research Center — Flint, Michigan
- Clinical Research Consultants — Kansas City, Missouri
- Albany Medical College — Albany, New York
- Carteret Medical Group — Morehead City, North Carolina
- Brookview Hills Research Associates, LLC — Winston-Salem, North Carolina
- Davita Clinical Research — El Paso, Texas
- Clinical Advancement Center — San Antonio, Texas
- Tekton Research — San Antonio, Texas
- Providence Medical Research Center — Spokane, Washington
- Centro Médico CIMEL — Lanús Este, Buenos Aires
- Renalida — Mar del Plata, Buenos Aires
- Centro de Investigaciones Metabólicas — City of Buenos Aires,
- Instituto de Cardiología de Corrientes — Corrientes,
- Instituto de Investigaciones Clinicas Mar Del Plata — Mar del Plata,
- Castle Hill Medical Centre — Castle Hill, New South Wales
- Gosford Renal Research — Gosford, New South Wales
📞 Contact the Study Coordinator
Phone: (866) 867-7178
Email: clinicaltrials@novonordisk.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chronic Kidney Disease
- Trial to Evaluate and Assess the Effect of Comprehensive Pre-ESKD Education on Home Dialysis Use in Veterans — Gainesville, Florida
- A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting — Huntsville, Alabama
- Nitrite-boosting Therapy for Improving Physiological Function in Patients With Chronic Kidney Disease — Boulder, Colorado
- "Residual Kidney Function and Oxidative Stress in Incremental vs Standard Peritoneal Dialysis (2 Mexican Centers)" — León, Guanajuato
- Dine and DASH Into Wellness Pilot Study — Durham, North Carolina
- An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States — Whippany, New Jersey
Explore by condition: All Chronic Kidney Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.